Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Melanoma Research|February 22, 2023
Methylation of nonessential genes in cutaneous melanoma - Rule Out hypothesisIvan P Gorlov, Kathleen Conway, Sharon N Edmiston, et al.
The Journal of Investigative Dermatology|December 12, 2018
Identification of a Robust Methylation Classifier for Cutaneous Melanoma DiagnosisKathleen Conway, Sharon N Edmiston, Joel S Parker, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 5, 2021
Disease-Associated Risk Variants in ANRIL Are Associated with Tumor-Infiltrating Lymphocyte Presence in Primary Melanomas in the Population-Based GEM StudyDanielle R Davari, Irene Orlow, Peter A Kanetsky, et al.
Biorxiv : the Preprint Server for Biology|February 12, 2026
Chromatin architecture and physical constriction cooperate in phenotype switching and cancer cell disseminationPietro Berico, Cody Dunton, Luay Almassalha, et al.
The Journal of Investigative Dermatology|May 13, 2018
Inherited Genetic Variants Associated with Melanoma BRAF/NRAS SubtypesNancy E Thomas, Sharon N Edmiston, Irene Orlow, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 4, 2025
Association of Inherited Genetic Variants with Multiple Primary MelanomaDavid C Gibbs, Brittany M Small, Isidora Autuori, et al.
The Journal of Investigative Dermatology|August 27, 2017
Associations of MC1R Genotype and Patient Phenotypes with BRAF and NRAS Mutations in MelanomaNancy E Thomas, Sharon N Edmiston, Peter A Kanetsky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2015
IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in MelanomaCraig C Carson, Stergios J Moschos, Sharon N Edmiston, et al.
JAMA Oncology|July 7, 2015
Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary MelanomaNancy E Thomas, Sharon N Edmiston, Audrey Alexander, et al.
Breast Cancer Research and Treatment|December 27, 2011
Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)Laura J Esserman, Donald A Berry, Maggie C U Cheang, et al.
Pageof 7